North America Custom Antibody Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service (Antibody Development, Antibody Production and Purification, and Antibody Fragmentation and Labelling); Type (Monoclonal Antibodies, Polyclonal Antibodies, and Other Custom Antibodies); Source (Mice, Rabbits, and Others); Research Area (Oncology, Immunology, Stem Cells, Infectious Diseases, Neurobiology, Cardiovascular Diseases, and Others); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations)

No. of Pages: 174    |    Report Code: TIPRE00023708    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Custom Antibody Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Custom Antibody Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Custom Antibody Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in biotechnology research and diagnostics
  • 5.1.2 Rising demand for custom antibodies in therapeutic and diagnostic applications
5.2 Market Opportunities
  • 5.2.1 Expansion in antibody therapies and diagnostics
  • 5.2.2 Rising opportunities for companies to invest in custom antibody development
5.3 Future Trends
  • 5.3.1 Use of monoclonal antibodies in personalized medicine
  • 5.3.2 Increasing trends in custom antibody development for targeted therapeutics
5.4 Impact of Drivers and Restraints

6. North America Custom Antibody Market Regional Analysis

6.1 North America Custom Antibody Market Overview
6.2 North America Custom Antibody Market Revenue 2019-2028 (US$ Million)
6.3 North America Custom Antibody Market Forecast Analysis

7. North America Custom Antibody Market Analysis – by Service

7.1 Antibody Development
  • 7.1.1 Overview
  • 7.1.2 Antibody Development: North America Custom Antibody Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Antibody Production and Purification
  • 7.2.1 Overview
  • 7.2.2 Antibody Production and Purification: North America Custom Antibody Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Antibody Fragmentation and Labelling
  • 7.3.1 Overview
  • 7.3.2 Antibody Fragmentation and Labelling: North America Custom Antibody Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Custom Antibody Market Analysis – by Type

8.1 Monoclonal Antibodies
  • 8.1.1 Overview
  • 8.1.2 Monoclonal Antibodies: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Polyclonal Antibodies
  • 8.2.1 Overview
  • 8.2.2 Polyclonal Antibodies: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Other Custom Antibodies
  • 8.3.1 Overview
  • 8.3.2 Other Custom Antibodies: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Custom Antibody Market Analysis – by Source

9.1 Mice
  • 9.1.1 Overview
  • 9.1.2 Other Custom Antibodies: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Rabbits
  • 9.2.1 Overview
  • 9.2.2 Other Custom Antibodies: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Custom Antibody Market – North America Analysis

10.1 North America
  • 10.1.1 North America Custom Antibody Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Custom Antibody Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Custom Antibody Market Breakdown, by Service
    • 10.1.1.1.2 US: North America Custom Antibody Market Breakdown, by Type
    • 10.1.1.1.3 US: North America Custom Antibody Market Breakdown, by Source
  • 10.1.1.2 Canada: North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Custom Antibody Market Breakdown, by Service
    • 10.1.1.2.2 Canada: North America Custom Antibody Market Breakdown, by Type
    • 10.1.1.2.3 Canada: North America Custom Antibody Market Breakdown, by Source
  • 10.1.1.3 Mexico : North America Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Custom Antibody Market Breakdown, by Service
    • 10.1.1.3.2 Mexico : North America Custom Antibody Market Breakdown, by Type
    • 10.1.1.3.3 Mexico : North America Custom Antibody Market Breakdown, by Source

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Custom Antibody Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bio-Rad Laboratories Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Merck KGAA
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Abcam
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Genscript
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Rockland Immunochemicals, Inc.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Promab
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Biolegend, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Agilent Technologies, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Cell Signaling Technology, Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - N Market

  1. Thermo Fisher Scientific Inc.
  2. Bio-Rad Laboratories Inc.
  3. Merck KGAA
  4. Abcam
  5. Genscript
  6. Rockland Immunochemicals, Inc.
  7. Promab
  8. Biolegend, Inc.
  9. Agilent Technologies, Inc.
  10. Cell Signaling Technology, Inc.
north-america-custom-antibody-market